Introduction
Patent Ductus Arteriosus (PDA) is a congenital heart condition where the ductus arteriosus—a blood vessel that connects the aorta and pulmonary artery in the fetus—fails to close after birth. This condition is particularly common in premature infants and can lead to symptoms like poor weight gain, difficulty breathing, and heart murmurs. If left untreated, PDA can result in long-term complications such as heart failure, pulmonary hypertension, or endocarditis.
Fortunately, advancements in pediatric cardiology have introduced minimally invasive solutions like Patent Ductus Arteriosus Device Closure Catheterization, a safe and highly effective procedure that eliminates the need for open-heart surgery.
In this technique, a small closure device is delivered via a catheter inserted through a vein or artery. The device blocks the abnormal blood flow through the ductus arteriosus, allowing the heart and lungs to function normally. This method is known as Transcatheter Closure of PDA and is widely recognized for its high success rates and quick recovery times in infants and children.
Types of PDA closure devices such as coils and occluders are chosen based on the size and shape of the PDA, ensuring a personalized approach for each patient.
This procedure has significantly improved outcomes in children with congenital heart defects. Parents can now look forward to a healthier future for their child—with minimal hospital stay and a faster return to normal activities—making life after PDA closure much more reassuring.